Clinical Trial: Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus for near vision).
Detailed Summary:
Sponsor: Allergan
Current Primary Outcome: Percentage of Participants With at Least a 2 Line Improvement From Baseline in Uncorrected Near Visual Acuity (UNVA) in the Non-Dominant Eye [ Time Frame: Baseline, Day 3 ]
Original Primary Outcome: Percentage of Participants with at Least a 2 Line Improvement from Baseline in Uncorrected Near Visual Acuity (UNVA) [ Time Frame: Baseline, Day 3 ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Allergan
Dates:
Date Received: July 21, 2014
Date Started: July 2014
Date Completion:
Last Updated: October 30, 2015
Last Verified: October 2015